| Insider Name | Current Shares | Net Change (1yr) | Buy/Sell Ratio |
|---|---|---|---|
| Capital Healthcare Fund LP RA | 26,975,505 | +8,434,972 | ∞ |
| plc GSK | 18,245,691 | +1,470,000 | ∞ |
| KEN TAKANASHI | 9,606,408 | +3,909,176 | 803.38 |
| CAPITAL MANAGEMENT, LLC RA | 7,775,207 | 0 | - |
| Shinsangyo Sousei Investment Limited Partnership Kagoshima | 2,794,865 | 0 | - |
| Masaharu Tanaka | 2,774,118 | 0 | - |
| Nippon Biomedical Laboratories, Ltd. Shin | 1,984,130 | 0 | - |
| Chandra Vargeese | 408,246 | +42,397 | 14.13 |
| Gregory L. Verdine | 283,197 | -39,320 | 0.24 |
| PAUL BOLNO | 275,520 | -62,831 | 0.72 |
| Kyle Moran | 134,385 | -17,999 | 0.72 |
| Chris Francis | 79,767 | +38,162 | 1.68 |
| Michael A. Panzara | 60,000 | 0 | - |
| Aik Na Tan | 57,630 | +49,009 | 2.65 |
| Adrian Rawcliffe | 54,700 | -3,415 | 0.94 |
| CHRISTIAN O HENRY | 54,700 | +38,585 | 3.39 |
| Heidi L Wagner | 51,930 | +12,700 | 2.81 |
| MARK CORRIGAN | 35,330 | +3,100 | 1.32 |
| Mark Baldry | 35,000 | 0 | - |
| Keith Regnante | 29,186 | 0 | - |
| ROBERTO GUERCIOLINI | 20,000 | 0 | - |
| David G Gaiero | 18,000 | 0 | - |
| Koji Miura | 10,500 | 0 | - |
| Peter Kolchinsky | 10,500 | 0 | - |
| Amy Pott | 10,500 | 0 | - |
| Takeshi Wada | 9,000 | 0 | - |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Capital Healthcare Fund LP RA | Mar 30 |
Open Market Purchase (P)
Market Purchase
|
26,975,505 | +971,091 | $6.50 | +$6,312,091 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Capital Healthcare Fund LP RA | Mar 30 |
Open Market Purchase (P)
Market Purchase
|
26,004,414 | +2,495,623 | $6.43 | +$16,046,855 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Capital Healthcare Fund LP RA | Mar 30 |
Open Market Purchase (P)
Market Purchase
|
23,157,567 | +4,954,558 | $6.06 | +$30,024,621 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| KEN TAKANASHI | Mar 26 |
Derivative Conversion (C)
Derivative Exercise
|
9,606,408 | +3,901,348 | $0.00 | +$0 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Chris Francis | Feb 27 |
Option Exercise/Conversion (M)
Compensation/Award
|
79,767 | +17,900 | $3.87 | +$69,273 |
| Chris Francis | Feb 27 |
Open Market Sale (S)
Market Sale
|
61,867 | -17,900 | $15.09 | -$270,182 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Kyle Moran | Feb 11 |
Open Market Sale (S)
Market Sale
|
134,385 | -3,588 | $13.45 | -$48,258 |
| PAUL BOLNO | Feb 11 |
Open Market Sale (S)
Market Sale
|
275,520 | -10,480 | $13.45 | -$140,956 |
| Chris Francis | Feb 11 |
Open Market Sale (S)
Market Sale
|
61,867 | -1,883 | $13.45 | -$25,326 |
| Chandra Vargeese | Feb 11 |
Open Market Sale (S)
Market Sale
|
408,246 | -3,228 | $13.45 | -$43,416 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Kyle Moran | Feb 11 |
Grant/Award Acquisition (A)
Compensation/Award
|
137,973 | +45,625 | $0.00 | +$0 |
| PAUL BOLNO | Feb 11 |
Grant/Award Acquisition (A)
Compensation/Award
|
286,000 | +165,000 | $0.00 | +$0 |
| Chris Francis | Feb 11 |
Grant/Award Acquisition (A)
Compensation/Award
|
63,750 | +38,750 | $0.00 | +$0 |
| Chandra Vargeese | Feb 11 |
Grant/Award Acquisition (A)
Compensation/Award
|
411,474 | +45,625 | $0.00 | +$0 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Chris Francis | Jan 06 |
Option Exercise/Conversion (M)
Compensation/Award
|
34,375 | +9,375 | $3.14 | +$29,437 |
| Chris Francis | Jan 06 |
Open Market Sale (S)
Market Sale
|
26,295 | -8,080 | $15.92 | -$128,633 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| plc GSK | Dec 15 |
Open Market Purchase (P)
Market Purchase
|
18,245,691 | +1,470,000 | $19.00 | +$27,930,000 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Kyle Moran | Dec 10 |
Grant/Award Acquisition (A)
Compensation/Award
|
0 | -36,000 | $0.00 | -$0 |
| Kyle Moran | Dec 10 |
Open Market Sale (S)
Market Sale
|
89,218 | -36 | $20.25 | -$729 |
| Kyle Moran | Dec 10 |
Option Exercise/Conversion (M)
Compensation/Award
|
125,218 | +36,000 | $8.17 | +$294,120 |
Loading...